Autophagy and multidrug resistance in cancer
Multidrug resistance (MDR) occurs frequently after long-term chemotherapy, resulting in refractory cancer and tumor recurrence. Therefore, combatting MDR is an important issue. Autophagy, a self-degradative system, universally arises during the treatment of sensitive and MDR cancer. Autophagy can be...
Saved in:
| Published in | Ai zheng Vol. 36; no. 8; pp. 342 - 351 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
24.06.2017
BioMed Central Ltd John Wiley & Sons, Inc Institute of Traditional Chinese Medicine & Natural Products, College of Pharmacy, Jinan University, Guangzhou 510632, Guangdong, P.R.China%Institute of Traditional Chinese Medicine & Natural Products, College of Pharmacy, Jinan University, Guangzhou 510632, Guangdong, P.R.China Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St.John's University, Queens, NY 11439, USA BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Multidrug resistance (MDR) occurs frequently after long-term chemotherapy, resulting in refractory cancer and tumor recurrence. Therefore, combatting MDR is an important issue. Autophagy, a self-degradative system, universally arises during the treatment of sensitive and MDR cancer. Autophagy can be a double-edged sword for MDR tumors: it participates in the development of MDR and protects cancer cells from chemotherapeutics but can also kill MDR cancer cells in which apoptosis pathways are inactive. Autophagy induced by anticancer drugs could also activate apoptosis signaling pathways in MDR cells, facilitating MDR reversal. Therefore, research on the regulation of autophagy to combat MDR is expanding and is becoming increasingly important. We summarize advanced studies of autophagy in MDR tumors, including the variable role of autophagy in MDR cancer cells. |
|---|---|
| AbstractList | Multidrug resistance (MDR) occurs frequently after long-term chemotherapy, resulting in refractory cancer and tumor recurrence. Therefore, combatting MDR is an important issue. Autophagy, a self-degradative system, universally arises during the treatment of sensitive and MDR cancer. Autophagy can be a double-edged sword for MDR tumors: it participates in the development of MDR and protects cancer cells from chemotherapeutics but can also kill MDR cancer cells in which apoptosis pathways are inactive. Autophagy induced by anticancer drugs could also activate apoptosis signaling pathways in MDR cells, facilitating MDR reversal. Therefore, research on the regulation of autophagy to combat MDR is expanding and is becoming increasingly important. We summarize advanced studies of autophagy in MDR tumors, including the variable role of autophagy in MDR cancer cells. Keywords: Autophagy, Drug resistance, Neoplasms, Cell survival, Cell death Multidrug resistance (MDR) occurs frequently after long-term chemotherapy,resulting in refractory cancer and tumor recurrence.Therefore,combatting MDR is an important issue.Autophagy,a self-degradative system,universally arises during the treatment of sensitive and MDR cancer.Autophagy can be a double-edged sword for MDR tumors:it participates in the development of MDR and protects cancer cells from chemotherapeutics but can also kill MDR cancer cells in which apoptosis pathways are inactive.Autophagy induced by anticancer drugs could also activate apoptosis signaling pathways in MDR cells,facilitating MDR reversal.Therefore,research on the regulation of autophagy to combat MDR is expanding and is becoming increasingly important.We summarize advanced studies of autophagy in MDR tumors,including the variable role of autophagy in MDR cancer cells. Multidrug resistance (MDR) occurs frequently after long-term chemotherapy, resulting in refractory cancer and tumor recurrence. Therefore, combatting MDR is an important issue. Autophagy, a self-degradative system, universally arises during the treatment of sensitive and MDR cancer. Autophagy can be a double-edged sword for MDR tumors: it participates in the development of MDR and protects cancer cells from chemotherapeutics but can also kill MDR cancer cells in which apoptosis pathways are inactive. Autophagy induced by anticancer drugs could also activate apoptosis signaling pathways in MDR cells, facilitating MDR reversal. Therefore, research on the regulation of autophagy to combat MDR is expanding and is becoming increasingly important. We summarize advanced studies of autophagy in MDR tumors, including the variable role of autophagy in MDR cancer cells.Multidrug resistance (MDR) occurs frequently after long-term chemotherapy, resulting in refractory cancer and tumor recurrence. Therefore, combatting MDR is an important issue. Autophagy, a self-degradative system, universally arises during the treatment of sensitive and MDR cancer. Autophagy can be a double-edged sword for MDR tumors: it participates in the development of MDR and protects cancer cells from chemotherapeutics but can also kill MDR cancer cells in which apoptosis pathways are inactive. Autophagy induced by anticancer drugs could also activate apoptosis signaling pathways in MDR cells, facilitating MDR reversal. Therefore, research on the regulation of autophagy to combat MDR is expanding and is becoming increasingly important. We summarize advanced studies of autophagy in MDR tumors, including the variable role of autophagy in MDR cancer cells. Abstract Multidrug resistance (MDR) occurs frequently after long-term chemotherapy, resulting in refractory cancer and tumor recurrence. Therefore, combatting MDR is an important issue. Autophagy, a self-degradative system, universally arises during the treatment of sensitive and MDR cancer. Autophagy can be a double-edged sword for MDR tumors: it participates in the development of MDR and protects cancer cells from chemotherapeutics but can also kill MDR cancer cells in which apoptosis pathways are inactive. Autophagy induced by anticancer drugs could also activate apoptosis signaling pathways in MDR cells, facilitating MDR reversal. Therefore, research on the regulation of autophagy to combat MDR is expanding and is becoming increasingly important. We summarize advanced studies of autophagy in MDR tumors, including the variable role of autophagy in MDR cancer cells. |
| ArticleNumber | 52 |
| Audience | Academic |
| Author | Ying-Jie Li;Yu-He Lei;Nan Yao;Chen-Ran Wang;Nan Hu;Wen-Cai Ye;Dong-Mei Zhang;Zhe-Sheng Chen |
| AuthorAffiliation | Institute of Traditional Chinese Medicine & Natural Products, College of Pharmacy, Jinan University, Guangzhou 510632, Guangdong, P. R.China;Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University, Queens, NY 11439, USA |
| AuthorAffiliation_xml | – name: Institute of Traditional Chinese Medicine & Natural Products, College of Pharmacy, Jinan University, Guangzhou 510632, Guangdong, P.R.China%Institute of Traditional Chinese Medicine & Natural Products, College of Pharmacy, Jinan University, Guangzhou 510632, Guangdong, P.R.China;Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St.John's University, Queens, NY 11439, USA |
| Author_xml | – sequence: 1 givenname: Ying‐Jie surname: Li fullname: Li, Ying‐Jie organization: Jinan University – sequence: 2 givenname: Yu‐He surname: Lei fullname: Lei, Yu‐He organization: Jinan University – sequence: 3 givenname: Nan surname: Yao fullname: Yao, Nan organization: Jinan University – sequence: 4 givenname: Chen‐Ran surname: Wang fullname: Wang, Chen‐Ran organization: Jinan University – sequence: 5 givenname: Nan surname: Hu fullname: Hu, Nan organization: Jinan University – sequence: 6 givenname: Wen‐Cai surname: Ye fullname: Ye, Wen‐Cai organization: Jinan University – sequence: 7 givenname: Dong‐Mei surname: Zhang fullname: Zhang, Dong‐Mei email: dmzhang701@foxmail.com organization: Jinan University – sequence: 8 givenname: Zhe‐Sheng surname: Chen fullname: Chen, Zhe‐Sheng email: chenz@stjohns.edu organization: St. John's University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28646911$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFk02L2zAQhk3Z0v1of0AvJVAoPdRbfVrSZSGEfiws9NAW9iZkWXIUHClr2S3pr-9kk002pbT4YDF-55mZV-Pz4iSm6IriJUaXGMvqfWZISlQiLEpEsCrJk-IMK8ZKxqrbEzgjhEpWidvT4jznBUIMKyGfFadEVqxSGJ8V76bjkFZz064nJjaT5dgNoenHdtK7HPJgonWTECd2c-ifF0-96bJ7sXtfFN8_fvg2-1zefPl0PZvelFYITEpjCPXCk9pz3zjLnDO-qhxnXtaqEg0SyhBVe2xrTpUlEKyhIdJQwxvjFb0orrfcJpmFXvVhafq1Tibo-0DqW236IdjOadtIgWtbKSQ4U1RKDwY0lTQOSapqBqyrLWs11kvXWBeH3nRH0OMvMcx1m35oziRRFQfA6y3gp4nexFYv0thHGF-7XwSsRxIhCqq3uzJ9uhtdHvQyZOu6zkSXxqyxwhR4VOIDcC_dE0HFGRGSq4OqNTBmiD5Bd3YD1VOOMa3ARQmqy7-o4GncMljYFh8gfpTw5lHC3JlumOfUjUNIMR8LXz32bW_Yw-qAAG8Ftk85987vJRjpzXrq7Xpq8Ehv1lMTyBF_5NgwmE1taDt0_8yc7m4BBlr_v5SeTWfk6310c0cQIwdL7TzF9i7AXT5wBPwpFEnOBf0NZ4AC8A |
| CitedBy_id | crossref_primary_10_1177_09731296231171217 crossref_primary_10_1016_j_semcdb_2019_05_006 crossref_primary_10_1016_j_lfs_2023_121798 crossref_primary_10_1080_14728222_2021_1992384 crossref_primary_10_1186_s12885_024_12588_w crossref_primary_10_1631_jzus_B2000076 crossref_primary_10_1007_s11596_022_2560_1 crossref_primary_10_1089_dna_2020_5667 crossref_primary_10_1007_s00432_021_03679_3 crossref_primary_10_3390_app14114548 crossref_primary_10_3389_fonc_2022_926296 crossref_primary_10_4251_wjgo_v15_i8_1384 crossref_primary_10_1155_2021_9986376 crossref_primary_10_1139_bcb_2021_0513 crossref_primary_10_1186_s12885_020_07535_4 crossref_primary_10_2217_nnm_2018_0284 crossref_primary_10_3389_fonc_2020_01613 crossref_primary_10_1007_s43440_020_00138_7 crossref_primary_10_3389_fonc_2020_00878 crossref_primary_10_1155_2019_5381692 crossref_primary_10_2174_1381612829666230426115424 crossref_primary_10_1002_jcp_30133 crossref_primary_10_1002_iub_2624 crossref_primary_10_1016_j_jpba_2023_115883 crossref_primary_10_4236_jbm_2024_1212034 crossref_primary_10_1016_j_cbi_2021_109479 crossref_primary_10_1002_cam4_5263 crossref_primary_10_3389_fonc_2022_880077 crossref_primary_10_1016_j_critrevonc_2020_103192 crossref_primary_10_1139_bcb_2022_0361 crossref_primary_10_3389_fonc_2023_1116061 crossref_primary_10_4103_jcrt_jcrt_215_23 crossref_primary_10_3390_cells12081156 crossref_primary_10_1016_j_bbrc_2021_11_088 crossref_primary_10_1186_s12943_019_1089_9 crossref_primary_10_1080_21655979_2021_1982274 crossref_primary_10_3892_mmr_2020_11492 crossref_primary_10_1016_j_biopha_2024_117119 crossref_primary_10_3390_ijms25147764 crossref_primary_10_3892_br_2024_1731 crossref_primary_10_3390_molecules28166118 crossref_primary_10_18632_aging_103947 crossref_primary_10_1016_j_ijpharm_2025_125508 crossref_primary_10_3390_diagnostics11030481 crossref_primary_10_1016_j_fct_2024_114968 crossref_primary_10_1186_s12943_020_01219_0 crossref_primary_10_1166_jbt_2022_3108 crossref_primary_10_1155_2022_7032614 crossref_primary_10_1002_smll_202207898 crossref_primary_10_3389_fbioe_2021_799806 crossref_primary_10_3389_fphar_2023_1274336 crossref_primary_10_3389_fonc_2022_873649 crossref_primary_10_3390_pharmaceutics14102181 crossref_primary_10_3390_ijms20174095 crossref_primary_10_3389_fcell_2022_1008576 crossref_primary_10_3389_fonc_2021_696705 crossref_primary_10_1007_s13258_021_01172_2 crossref_primary_10_1007_s13402_020_00578_6 crossref_primary_10_1007_s11033_018_4358_6 crossref_primary_10_31083_j_fbl2906212 crossref_primary_10_1016_j_omtn_2021_01_002 crossref_primary_10_1124_molpharm_121_000234 crossref_primary_10_3390_ijms231810378 crossref_primary_10_1080_08916934_2023_2259125 crossref_primary_10_1016_j_phrs_2023_106769 crossref_primary_10_1016_j_drup_2022_100866 crossref_primary_10_1002_slct_202103495 crossref_primary_10_3389_fcell_2021_674919 crossref_primary_10_2174_1381612826666200406083756 crossref_primary_10_1515_med_2023_0799 crossref_primary_10_1002_ptr_7096 crossref_primary_10_1016_j_ecoenv_2023_115628 crossref_primary_10_3389_fcell_2020_607757 crossref_primary_10_1016_j_bcp_2024_116588 crossref_primary_10_1002_fsn3_3231 crossref_primary_10_1016_j_carbpol_2020_117284 crossref_primary_10_3389_fmolb_2024_1327459 crossref_primary_10_1021_acsomega_4c09755 crossref_primary_10_1002_kjm2_12696 crossref_primary_10_1016_j_bbrc_2022_03_075 crossref_primary_10_1097_CAD_0000000000001518 crossref_primary_10_3390_antiox14010029 crossref_primary_10_1096_fj_202200400RR crossref_primary_10_1021_acsabm_0c00705 crossref_primary_10_1007_s00253_019_10257_8 crossref_primary_10_1007_s00383_024_05712_1 crossref_primary_10_1097_CM9_0000000000003090 crossref_primary_10_7759_cureus_28496 crossref_primary_10_3389_fonc_2022_965628 crossref_primary_10_1042_BSR20180915 crossref_primary_10_1002_mabi_202300116 crossref_primary_10_1155_2022_2055676 crossref_primary_10_3389_fonc_2020_573502 crossref_primary_10_3389_fonc_2021_658636 crossref_primary_10_1155_2021_8877460 crossref_primary_10_1016_j_biocel_2019_105663 crossref_primary_10_1038_s41598_019_56273_6 crossref_primary_10_1515_oncologie_2023_0530 crossref_primary_10_3390_ijms241713474 crossref_primary_10_1007_s00005_021_00629_2 crossref_primary_10_1007_s11596_021_2374_6 crossref_primary_10_1016_j_canlet_2020_11_045 crossref_primary_10_1038_s41416_020_0839_1 crossref_primary_10_1080_10717544_2022_2079771 crossref_primary_10_1007_s10517_023_05734_0 crossref_primary_10_3390_ijms21186521 crossref_primary_10_1155_2022_7354700 crossref_primary_10_3390_molecules27030616 crossref_primary_10_1007_s11302_023_09975_6 crossref_primary_10_1093_jpp_rgad116 crossref_primary_10_3390_cancers16172989 crossref_primary_10_1002_cmdc_202300374 crossref_primary_10_1016_j_xcrm_2022_100741 crossref_primary_10_1134_S1990519X23050139 crossref_primary_10_2174_1381612829666230614154847 crossref_primary_10_1186_s40164_024_00569_5 crossref_primary_10_1007_s10528_023_10330_y crossref_primary_10_1186_s12964_023_01444_2 crossref_primary_10_3390_cells9071593 crossref_primary_10_1016_j_phymed_2022_154411 crossref_primary_10_1177_1721727X241260258 crossref_primary_10_3389_fphar_2020_00787 crossref_primary_10_1016_j_medidd_2020_100024 crossref_primary_10_2147_OTT_S247398 crossref_primary_10_1016_S2707_3688_23_00001_8 crossref_primary_10_3389_fphar_2020_00547 crossref_primary_10_1186_s13046_021_01974_y crossref_primary_10_1016_j_drup_2021_100769 crossref_primary_10_1002_hep_32102 crossref_primary_10_1186_s12967_023_04265_6 crossref_primary_10_3390_ijms22010179 crossref_primary_10_4103_jcrt_jcrt_625_22 crossref_primary_10_3892_ol_2024_14719 crossref_primary_10_1016_j_bbamcr_2023_119537 crossref_primary_10_1093_jpp_rgaa027 crossref_primary_10_2147_PGPM_S267563 crossref_primary_10_1111_neup_12824 crossref_primary_10_1007_s12032_024_02528_w crossref_primary_10_1007_s00438_024_02165_y crossref_primary_10_1155_2022_4589182 crossref_primary_10_1007_s41061_019_0240_9 crossref_primary_10_31857_S0023291223600608 crossref_primary_10_1002_ddr_21878 crossref_primary_10_3892_ol_2021_12956 crossref_primary_10_1007_s12032_023_01980_4 crossref_primary_10_1155_2021_5631942 crossref_primary_10_3389_fonc_2020_541262 crossref_primary_10_3389_fphar_2021_799588 crossref_primary_10_3390_microorganisms12061235 crossref_primary_10_1016_j_bbrc_2023_03_046 crossref_primary_10_1016_j_bbrc_2019_04_111 crossref_primary_10_1186_s12935_022_02505_1 crossref_primary_10_3390_genes12111835 crossref_primary_10_1186_s11658_024_00571_z crossref_primary_10_1002_kjm2_12191 crossref_primary_10_1038_s41392_022_01168_8 crossref_primary_10_2174_0118715206316284240807100226 crossref_primary_10_1007_s10330_021_0497_7 crossref_primary_10_3389_fcell_2020_00584 crossref_primary_10_1007_s12094_022_02910_y crossref_primary_10_3892_mmr_2022_12617 crossref_primary_10_1016_j_biopha_2024_116310 crossref_primary_10_3390_ijms232213990 crossref_primary_10_1016_j_bioactmat_2022_12_027 crossref_primary_10_3389_fphar_2019_01503 crossref_primary_10_2174_1871520621666210608104021 crossref_primary_10_3389_fonc_2023_1220435 crossref_primary_10_1016_j_biopha_2021_112005 crossref_primary_10_1111_jcmm_14651 crossref_primary_10_1038_s41419_021_03650_7 crossref_primary_10_1038_s41419_022_04974_8 crossref_primary_10_3390_cells12242790 crossref_primary_10_1016_j_cellsig_2025_111679 crossref_primary_10_1007_s00280_021_04393_0 crossref_primary_10_1016_j_ajps_2020_03_001 crossref_primary_10_3390_ijms20092085 crossref_primary_10_1186_s13578_021_00570_z crossref_primary_10_3389_fgene_2022_834935 crossref_primary_10_3389_fphar_2021_709324 crossref_primary_10_3390_cancers14071637 crossref_primary_10_1016_j_biopha_2021_111227 crossref_primary_10_1016_j_rechem_2025_102059 crossref_primary_10_3390_cancers11081209 crossref_primary_10_3389_fphar_2023_1172939 crossref_primary_10_1186_s12967_023_04365_3 crossref_primary_10_3389_fphar_2022_903599 crossref_primary_10_1016_j_cellsig_2024_111483 crossref_primary_10_3390_ijms21238991 crossref_primary_10_1016_j_arabjc_2023_105448 crossref_primary_10_1177_1934578X231161414 crossref_primary_10_3389_pore_2023_1611300 crossref_primary_10_3892_mmr_2021_12405 crossref_primary_10_1080_21655979_2022_2086377 crossref_primary_10_1016_j_ecoenv_2023_115575 crossref_primary_10_1038_s41420_024_01958_9 crossref_primary_10_1111_jcmm_16658 crossref_primary_10_1016_j_tranon_2020_100851 crossref_primary_10_1186_s12951_022_01377_x crossref_primary_10_1002_ptr_7361 crossref_primary_10_1016_j_biopha_2021_111223 crossref_primary_10_1177_1010428320925237 crossref_primary_10_2147_OTT_S247655 crossref_primary_10_3389_fonc_2022_841625 crossref_primary_10_1002_ptr_7009 crossref_primary_10_3389_fimmu_2024_1412781 crossref_primary_10_1096_fj_202401409R crossref_primary_10_3892_ijmm_2021_5047 crossref_primary_10_1016_j_biopha_2019_108957 crossref_primary_10_1159_000512614 crossref_primary_10_1016_j_apsb_2020_12_009 crossref_primary_10_3390_molecules26040934 crossref_primary_10_3390_ph15091131 crossref_primary_10_3390_ijms251910646 crossref_primary_10_1039_D4MD00136B crossref_primary_10_3892_ijmm_2020_4521 crossref_primary_10_1139_cjpp_2019_0477 crossref_primary_10_3390_ijms22094787 crossref_primary_10_1002_ptr_7231 crossref_primary_10_3390_pharmaceutics14122551 crossref_primary_10_1007_s10404_024_02724_0 crossref_primary_10_2174_0929866526666190926154248 crossref_primary_10_7717_peerj_11968 crossref_primary_10_2174_0929867328666210910124319 crossref_primary_10_1002_cam4_5407 crossref_primary_10_1016_j_bios_2023_115985 crossref_primary_10_3892_ol_2021_12893 crossref_primary_10_1016_j_tranon_2020_100871 crossref_primary_10_1186_s13071_022_05274_y crossref_primary_10_1016_j_abb_2020_108285 crossref_primary_10_3390_ijms20030725 crossref_primary_10_1016_j_pep_2025_106663 crossref_primary_10_1002_ptr_7221 crossref_primary_10_1042_BSR20210462 crossref_primary_10_3389_fgene_2022_885391 crossref_primary_10_1080_1120009X_2021_2011661 crossref_primary_10_1016_j_plipres_2018_12_002 crossref_primary_10_1016_j_comtox_2019_100095 crossref_primary_10_1038_s41598_021_98728_9 crossref_primary_10_3389_fonc_2021_716757 crossref_primary_10_3389_fonc_2020_01744 crossref_primary_10_1007_s11033_021_06817_9 crossref_primary_10_1186_s11671_019_3143_3 crossref_primary_10_1089_jmf_2020_0200 crossref_primary_10_1002_SMMD_20220013 crossref_primary_10_1007_s13577_019_00295_9 crossref_primary_10_1248_bpb_b21_00511 crossref_primary_10_1007_s00210_024_03354_7 crossref_primary_10_3892_ijmm_2019_4427 crossref_primary_10_1007_s43188_023_00191_3 crossref_primary_10_1155_2021_2401617 crossref_primary_10_3390_cancers16173082 crossref_primary_10_18632_aging_103117 crossref_primary_10_1007_s10456_020_09716_y crossref_primary_10_1016_j_biopha_2024_116855 crossref_primary_10_1039_D2NA00355D crossref_primary_10_3390_cancers14133217 crossref_primary_10_1080_21655979_2021_2012918 crossref_primary_10_1002_tox_22769 crossref_primary_10_3389_fcell_2021_651021 crossref_primary_10_3390_biom12071010 crossref_primary_10_1039_D0CS01370F crossref_primary_10_3389_fonc_2022_1006114 crossref_primary_10_3390_ijms21062143 crossref_primary_10_1186_s12943_022_01620_x crossref_primary_10_3389_fphar_2022_935155 crossref_primary_10_3390_ijerph182111125 crossref_primary_10_1080_15548627_2021_2002108 crossref_primary_10_3390_biom11020135 crossref_primary_10_1016_j_ejmech_2019_05_027 crossref_primary_10_2174_1871520621666210528144006 crossref_primary_10_1016_j_biopha_2023_114487 crossref_primary_10_3389_fimmu_2023_1250920 crossref_primary_10_1186_s12885_020_07605_7 crossref_primary_10_3390_cancers15123199 crossref_primary_10_1016_j_ncrna_2024_06_004 crossref_primary_10_2174_1574892816666210607100239 crossref_primary_10_1016_j_dnarep_2020_103032 crossref_primary_10_1016_j_bmc_2023_117486 crossref_primary_10_3390_ijms21155221 crossref_primary_10_1038_s41598_024_55138_x crossref_primary_10_1016_j_mcp_2024_101961 crossref_primary_10_1002_iid3_845 crossref_primary_10_1186_s12885_020_07725_0 crossref_primary_10_1111_cas_13711 crossref_primary_10_3389_fcell_2022_808591 crossref_primary_10_4062_biomolther_2022_019 crossref_primary_10_3390_ijms23073544 crossref_primary_10_1016_j_bulcan_2020_11_004 crossref_primary_10_1177_08853282211060252 crossref_primary_10_3390_cancers12071963 crossref_primary_10_3390_nu14132622 crossref_primary_10_3233_CBM_181681 crossref_primary_10_3389_fmolb_2021_763500 crossref_primary_10_1002_cam4_1770 crossref_primary_10_1016_j_yexmp_2020_104367 crossref_primary_10_1038_s41419_019_2181_1 crossref_primary_10_3390_ijms25010251 crossref_primary_10_1016_j_nano_2020_102340 crossref_primary_10_1016_j_actbio_2024_10_025 crossref_primary_10_3390_ijms24087069 crossref_primary_10_1016_j_biomaterials_2022_121434 crossref_primary_10_1007_s11010_022_04470_9 crossref_primary_10_3892_ijo_2024_5712 crossref_primary_10_1016_j_jare_2022_09_007 crossref_primary_10_1134_S1061933X23600690 crossref_primary_10_3390_cancers13153688 crossref_primary_10_1016_j_gene_2020_144974 crossref_primary_10_1111_1759_7714_15234 crossref_primary_10_1016_j_yexmp_2020_104592 crossref_primary_10_1039_D3BM01741A crossref_primary_10_3892_ol_2019_10980 crossref_primary_10_1007_s12020_020_02417_y crossref_primary_10_4062_biomolther_2019_103 crossref_primary_10_3389_fonc_2020_587343 crossref_primary_10_1371_journal_pone_0210513 crossref_primary_10_1016_j_actbio_2024_07_019 crossref_primary_10_1186_s12935_020_01267_y crossref_primary_10_1021_acsabm_4c01318 crossref_primary_10_3390_ijms25137459 crossref_primary_10_1242_bio_038000 crossref_primary_10_3892_etm_2021_10412 crossref_primary_10_1016_j_intimp_2023_110602 crossref_primary_10_3389_fimmu_2024_1520072 crossref_primary_10_3389_fphar_2021_755366 crossref_primary_10_1016_j_canlet_2024_216823 crossref_primary_10_3892_ijmm_2022_5186 crossref_primary_10_3892_ol_2022_13467 crossref_primary_10_1002_biot_202200147 crossref_primary_10_2174_1574892815999200824122723 crossref_primary_10_1016_j_gene_2019_06_025 crossref_primary_10_1111_cbdd_14225 crossref_primary_10_1002_cbin_12055 crossref_primary_10_1186_s12905_022_01667_4 crossref_primary_10_1016_j_biopha_2018_01_140 crossref_primary_10_32604_oncologie_2021_018514 crossref_primary_10_1016_j_bbcan_2021_188552 crossref_primary_10_1016_j_ejmech_2024_116179 crossref_primary_10_1038_s41420_022_00886_w crossref_primary_10_1007_s10557_023_07483_8 crossref_primary_10_1016_j_ijbiomac_2023_123663 crossref_primary_10_3389_fphar_2023_1176232 crossref_primary_10_3390_md16070238 crossref_primary_10_1111_1759_7714_13295 crossref_primary_10_1080_10286020_2024_2386678 crossref_primary_10_1007_s12032_021_01638_z crossref_primary_10_1186_s40364_023_00467_8 crossref_primary_10_3389_fphar_2021_684915 crossref_primary_10_1016_j_biopha_2020_110254 crossref_primary_10_3390_cancers12010109 crossref_primary_10_1016_j_biopha_2020_110490 crossref_primary_10_2174_1389557522666220905090732 crossref_primary_10_1016_j_canlet_2018_02_024 crossref_primary_10_2174_1386207324666210826143727 crossref_primary_10_1016_j_intimp_2023_110603 crossref_primary_10_3390_ijms22042084 crossref_primary_10_3892_ijo_2024_5627 crossref_primary_10_1016_j_bbcan_2020_188488 crossref_primary_10_1016_j_ejphar_2019_04_001 crossref_primary_10_1016_j_ica_2022_120929 crossref_primary_10_3389_fphar_2023_1114295 crossref_primary_10_3390_biomedicines10030707 crossref_primary_10_31857_S0041377123030100 crossref_primary_10_3390_ijms24021257 crossref_primary_10_1021_acsami_2c09443 crossref_primary_10_1111_1440_1681_13718 crossref_primary_10_3389_fonc_2024_1364070 crossref_primary_10_3389_fphar_2018_00092 crossref_primary_10_1007_s42242_023_00263_1 crossref_primary_10_1021_acs_joc_7b01602 crossref_primary_10_1016_j_bioorg_2024_107327 crossref_primary_10_1007_s12094_023_03160_2 crossref_primary_10_1016_j_drup_2021_100754 crossref_primary_10_3389_fonc_2020_00920 crossref_primary_10_1016_j_heliyon_2023_e15367 crossref_primary_10_1016_j_phymed_2024_155647 crossref_primary_10_3390_bios13020235 crossref_primary_10_3892_etm_2021_10364 crossref_primary_10_1002_mc_23460 crossref_primary_10_32604_or_2023_030988 crossref_primary_10_1155_2021_8810849 crossref_primary_10_1016_j_biopha_2023_115984 crossref_primary_10_1016_j_drup_2023_101042 crossref_primary_10_1159_000539642 crossref_primary_10_1016_j_ijbiomac_2024_139155 crossref_primary_10_3389_fonc_2021_614458 crossref_primary_10_1097_CAD_0000000000000572 crossref_primary_10_18632_aging_102427 crossref_primary_10_1007_s43440_020_00122_1 crossref_primary_10_1038_s41598_023_49578_0 crossref_primary_10_1177_1758835920927602 crossref_primary_10_3390_antiox10111801 crossref_primary_10_3389_fimmu_2021_641937 crossref_primary_10_1002_mc_23590 crossref_primary_10_1016_j_bbrc_2022_11_084 crossref_primary_10_3390_ph17030361 crossref_primary_10_2147_OTT_S239336 crossref_primary_10_3390_molecules26154389 crossref_primary_10_2147_OTT_S243953 crossref_primary_10_1038_s41419_021_03394_4 crossref_primary_10_3390_nu14030699 crossref_primary_10_1186_s12935_019_0869_z crossref_primary_10_1016_j_ctarc_2022_100512 crossref_primary_10_1016_j_jddst_2021_102954 crossref_primary_10_3390_ijms25084377 crossref_primary_10_3389_fcell_2023_1177440 crossref_primary_10_1016_j_canlet_2024_217285 crossref_primary_10_3389_fonc_2022_975758 crossref_primary_10_3389_fonc_2023_1132141 crossref_primary_10_1016_j_biopha_2017_12_038 crossref_primary_10_3390_ijms241813713 crossref_primary_10_3390_pharmaceutics15020584 crossref_primary_10_1186_s13578_022_00752_3 crossref_primary_10_3389_fonc_2020_586069 crossref_primary_10_32604_or_2024_048778 crossref_primary_10_1002_cbin_11609 crossref_primary_10_1016_j_mvr_2020_104023 crossref_primary_10_3389_fphar_2024_1469830 crossref_primary_10_1038_s41419_021_04474_1 crossref_primary_10_1016_j_biopha_2023_114505 crossref_primary_10_3390_ijms23020657 crossref_primary_10_3389_fonc_2024_1379698 crossref_primary_10_3390_ijms241813827 crossref_primary_10_3389_fonc_2019_00487 crossref_primary_10_1016_j_prp_2021_153735 crossref_primary_10_3389_fphar_2022_943272 crossref_primary_10_1186_s12951_022_01514_6 crossref_primary_10_3389_fphar_2022_1043056 crossref_primary_10_1016_j_leukres_2019_106198 crossref_primary_10_2217_bmm_2021_0649 crossref_primary_10_1016_j_isci_2022_104471 crossref_primary_10_1155_2022_9390611 crossref_primary_10_1038_s41419_022_04550_0 crossref_primary_10_3390_ijms22031318 crossref_primary_10_1016_j_drup_2020_100715 crossref_primary_10_3390_ijms242216413 crossref_primary_10_1080_17512433_2020_1758063 crossref_primary_10_1002_cnr2_70033 crossref_primary_10_1007_s12032_021_01562_2 crossref_primary_10_1155_2020_1903627 crossref_primary_10_1016_j_ijpharm_2024_123970 crossref_primary_10_3390_molecules29143388 crossref_primary_10_1016_j_bmc_2022_116894 crossref_primary_10_18632_aging_204097 crossref_primary_10_3390_cancers16071267 crossref_primary_10_1016_j_bcp_2020_113856 crossref_primary_10_3390_medicina58020319 crossref_primary_10_1007_s13577_023_00900_y crossref_primary_10_3389_fonc_2021_595099 crossref_primary_10_2174_0115701646317215240712103448 crossref_primary_10_7717_peerj_16517 crossref_primary_10_1016_j_ijpharm_2021_120973 crossref_primary_10_1007_s00280_023_04582_z crossref_primary_10_1007_s12032_023_02237_w crossref_primary_10_3390_biomedicines11102706 crossref_primary_10_1093_rb_rbae141 crossref_primary_10_3390_ijms23147594 crossref_primary_10_3390_ijms241914470 crossref_primary_10_1016_S1875_5364_24_60638_2 crossref_primary_10_3389_fonc_2023_1135401 crossref_primary_10_3390_biomedicines12071484 crossref_primary_10_1016_j_biopha_2019_109473 crossref_primary_10_3390_cells13110948 crossref_primary_10_7717_peerj_15535 crossref_primary_10_1002_cnr2_1291 crossref_primary_10_3390_cancers15164187 crossref_primary_10_1007_s12094_021_02630_9 crossref_primary_10_1038_s41418_024_01426_y crossref_primary_10_1016_j_drup_2023_101028 crossref_primary_10_1186_s12951_019_0550_7 crossref_primary_10_3389_fonc_2022_925379 crossref_primary_10_3390_molecules24020336 crossref_primary_10_3390_ijms22179286 crossref_primary_10_3390_medicina57090879 crossref_primary_10_3389_fphar_2024_1348076 crossref_primary_10_1038_s41420_021_00677_9 crossref_primary_10_1186_s13073_018_0562_1 crossref_primary_10_3390_molecules26041113 crossref_primary_10_1186_s41065_023_00294_9 crossref_primary_10_1016_j_tiv_2023_105603 crossref_primary_10_1021_acs_jmedchem_2c02061 crossref_primary_10_1021_acsami_1c19022 crossref_primary_10_15275_rusomj_2022_0115 crossref_primary_10_1038_s41419_018_0681_z crossref_primary_10_3389_fonc_2022_903016 crossref_primary_10_3390_metabo13050642 crossref_primary_10_3390_molecules28227594 |
| Cites_doi | 10.1016/j.cell.2013.08.044 10.1371/journal.pone.0125774 10.4161/auto.7.1.14071 10.18632/oncotarget.5632 10.1038/35044114 10.1038/cddis.2011.139 10.1038/modpathol.3880407 10.1371/journal.pone.0006251 10.1038/sj.onc.1209377 10.1158/1078-0432.CCR-13-2060 10.1371/journal.pone.0097242 10.1002/ijc.25771 10.1089/cbr.2009.0701 10.1186/1476-4598-13-165 10.1016/j.ijpharm.2015.10.009 10.4161/auto.5.8.9842 10.4161/auto.6.8.13614 10.1172/JCI70454 10.1111/j.1365-2443.2008.01188.x 10.1016/j.biopha.2011.12.002 10.1038/26506 10.4161/auto.7.9.16521 10.4161/auto.6058 10.1182/blood.V86.3.1148.1148 10.1038/nrc2254 10.1088/0957-4484/21/49/495101 10.4161/auto.6952 10.3390/molecules190913848 10.1186/1741-7007-9-38 10.1038/ncb1846 10.1182/blood-2006-10-050260 10.1016/j.molcel.2011.04.024 10.1016/j.cmet.2011.04.004 10.1124/mol.105.017988 10.1038/aps.2013.35 10.3892/ijo.2014.2297 10.1126/science.2799391 10.4161/auto.21812 10.7150/ijms.5011 10.1016/j.bbrc.2012.06.048 10.4149/neo_2015_025 10.1021/mp5000696 10.1080/15548627.2015.1033601 10.1038/cddis.2015.123 10.1007/s10495-016-1214-9 10.1186/1475-2867-11-3 10.1158/0008-5472.CAN-11-3396 10.1093/toxsci/kfj127 10.1074/jbc.M703663200 10.1002/path.3025 10.1016/j.biopha.2015.03.009 10.1093/jnci/92.1.4 10.1016/j.cell.2007.12.018 10.4161/auto.26058 10.1007/s11010-011-1199-1 10.4161/auto.7.5.15066 10.1016/j.biopha.2016.04.054 10.1016/j.phymed.2015.03.010 10.1038/nrd3028 10.1158/1535-7163.MCT-07-0487 10.18632/oncotarget.2192 10.1074/jbc.M109.053520 10.1128/MCB.06159-11 10.1093/emboj/20.21.5971 10.18632/oncotarget.8048 10.1038/nrclinonc.2014.104 10.1038/ncb2788 10.1158/0008-5472.CAN-06-4766 10.3892/ijmm.2011.806 10.7554/eLife.00947 10.1038/nature11910 10.1016/j.humpath.2015.07.016 10.1007/s10059-011-0034-6 10.1038/nature09076 10.1038/nrc1590 10.5732/cjc.013.10122 10.1016/j.canlet.2011.06.034 10.1093/jac/dkq324 10.1016/j.toxlet.2013.04.021 10.1126/scisignal.2001017 10.1371/journal.pone.0110293 10.1186/2045-3701-4-49 10.18632/oncotarget.6980 10.1186/s40880-015-0006-x 10.1016/j.bbamcr.2011.10.014 10.4161/cc.29335 10.3390/cells1030558 10.1007/s10549-007-9873-4 10.3390/cancers6041925 10.1038/emboj.2012.278 10.1166/jbn.2016.2232 10.1080/08982104.2016.1185731 10.1083/jcb.200712064 10.1007/s10549-013-2607-x 10.1038/nrc3599 |
| ContentType | Journal Article |
| Copyright | 2017 The Author(s) COPYRIGHT 2017 BioMed Central Ltd. Copyright BioMed Central 2017 Copyright © Wanfang Data Co. Ltd. All Rights Reserved. The Author(s) 2017 |
| Copyright_xml | – notice: 2017 The Author(s) – notice: COPYRIGHT 2017 BioMed Central Ltd. – notice: Copyright BioMed Central 2017 – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. – notice: The Author(s) 2017 |
| DBID | 2RA 92L CQIGP W91 ~WA 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9- K9. KB0 M0R M0S M1P NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 2B. 4A8 92I 93N PSX TCJ 5PM DOA |
| DOI | 10.1186/s40880-017-0219-2 |
| DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Consumer Health Database ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) PubMed Central (Full Participant titles) Open Access资源_DOAJ |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 24P name: Wiley Online Library Open Access (WRLC) url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1944-446X 2523-3548 |
| EndPage | 351 |
| ExternalDocumentID | oai_doaj_org_article_cd871bc6907549388f194d68ae0839b4 PMC5482965 ez201708003 A511360798 28646911 10_1186_s40880_017_0219_2 CAC2S4088001702192 7000308557 |
| Genre | reviewArticle Journal Article Review |
| GrantInformation_xml | – fundername: Program for New Century Excellent Talents in University – fundername: Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme – fundername: Natural Science Foundation of Guangdong Province funderid: S2013050014183; 2013CXZDA006 – fundername: Science and Technology Program of China funderid: 2012ZX09103101‐053 – fundername: This study was supported by the Science and Technology Program of China; the Natural Science Foundation of Guangdong Province; the Program for New Century Excellent Talents in University; the project was supported by Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme funderid: (2012ZX09103101-053); (S2013050014183 and 2013CXZDA006); the Program for New Century Excellent Talents in University; the project was supported by Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme – fundername: ; – fundername: ; grantid: 2012ZX09103101-053 – fundername: ; grantid: S2013050014183 |
| GroupedDBID | --- -05 -0E -S~ 2B. 2C~ 2RA 3V. 5VS 5XA 5XF 92F 92I 92L 92M 93N 93R ACGFS ADBBV ADINQ ADRAZ AENEX AFGXO AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP BCNDV BENPR BPHCQ BVXVI C24 CCEZO CHBEP CIEJG CQIGP CW9 DIK EJD F5P FA0 GROUPED_DOAJ HYE IAO IHR IHW ITC JUIAU KQ8 M48 M~E OK1 P2P PIMPY PQQKQ PROAC R-E RBZ RNS ROL RPM RSV RT5 S.. T8U TCJ TGQ U1F U1G U5E U5O W91 ~WA 0R~ 1OC 24P 7RV 7X7 88E 8FI 8FJ ABUWG ACCMX ACRMQ ACXQS ADKYN ADPDF ADUKV ADZMN ADZOD AFKRA AHSBF ALUQN AVUZU AZQEC BMC C6C CCPQU EBS FYUFA HMCUK K9- M0R M1P NAPCQ OVD OVEED PSQYO SOJ TEORI UKHRP WIN AAYXX ABJNI CITATION H13 PGMZT CGR CUY CVF ECM EIF NPM 7XB 8FK DWQXO K9. PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 4A8 PSX 5PM |
| ID | FETCH-LOGICAL-c7712-aa23f7f2bf5fdec4eeaf66e54f8b967d079a29bf1cb539c2b96b8642d3a5daf93 |
| IEDL.DBID | 24P |
| ISSN | 1000-467X 2523-3548 1944-446X |
| IngestDate | Wed Aug 27 01:12:34 EDT 2025 Thu Aug 21 18:23:06 EDT 2025 Thu May 29 04:02:53 EDT 2025 Fri Jul 11 09:16:06 EDT 2025 Wed Aug 13 04:02:49 EDT 2025 Tue Mar 18 23:18:21 EDT 2025 Sat Mar 08 18:35:44 EST 2025 Thu May 22 21:23:03 EDT 2025 Mon Jul 21 06:07:13 EDT 2025 Tue Jul 01 02:34:58 EDT 2025 Thu Apr 24 22:57:56 EDT 2025 Wed Jan 22 16:37:10 EST 2025 Wed Feb 14 09:57:38 EST 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Keywords | Cell survival Drug resistance Cell death Autophagy Neoplasms |
| Language | English |
| License | Attribution Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c7712-aa23f7f2bf5fdec4eeaf66e54f8b967d079a29bf1cb539c2b96b8642d3a5daf93 |
| Notes | 44-1195/R Ying‐Jie Li and Yu‐He Lei contributed equally to this work ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1186%2Fs40880-017-0219-2 |
| PMID | 28646911 |
| PQID | 1915427859 |
| PQPubID | 2040150 |
| PageCount | 10 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_cd871bc6907549388f194d68ae0839b4 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5482965 wanfang_journals_ez201708003 proquest_miscellaneous_1913829381 proquest_journals_1915427859 gale_infotracmisc_A511360798 gale_infotracacademiconefile_A511360798 gale_healthsolutions_A511360798 pubmed_primary_28646911 crossref_primary_10_1186_s40880_017_0219_2 crossref_citationtrail_10_1186_s40880_017_0219_2 wiley_primary_10_1186_s40880_017_0219_2_CAC2S4088001702192 chongqing_primary_7000308557 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2017-06-24 |
| PublicationDateYYYYMMDD | 2017-06-24 |
| PublicationDate_xml | – month: 06 year: 2017 text: 2017-06-24 day: 24 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Ai zheng |
| PublicationTitleAlternate | Chinese Journal of Cancer |
| PublicationTitle_FL | Chinese Journal of Cancer |
| PublicationYear | 2017 |
| Publisher | BioMed Central BioMed Central Ltd John Wiley & Sons, Inc Institute of Traditional Chinese Medicine & Natural Products, College of Pharmacy, Jinan University, Guangzhou 510632, Guangdong, P.R.China%Institute of Traditional Chinese Medicine & Natural Products, College of Pharmacy, Jinan University, Guangzhou 510632, Guangdong, P.R.China Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St.John's University, Queens, NY 11439, USA BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: John Wiley & Sons, Inc – name: Institute of Traditional Chinese Medicine & Natural Products, College of Pharmacy, Jinan University, Guangzhou 510632, Guangdong, P.R.China%Institute of Traditional Chinese Medicine & Natural Products, College of Pharmacy, Jinan University, Guangzhou 510632, Guangdong, P.R.China – name: Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St.John's University, Queens, NY 11439, USA – name: BMC |
| References | 2015; 34 2012; 364 2013; 2 2015; 72 2010; 465 2008; 7 2000; 92 2011; 11 2011; 13 2008; 4 2011; 310 1998; 395 2013; 9 2014; 20 2012; 72 2015; 46 2009; 11 2000; 408 2010; 65 2010; 21 2013; 15 2014; 5 2014; 4 2010; 25 2011; 129 2013; 13 2006; 25 2006; 69 2015; 495 2014; 13 2007; 7 2012; 29 2014; 19 2016; 82 2013; 154 2014; 9 2008; 112 2010; 3 2001; 14 2014; 6 2012; 66 2007; 67 2014; 11 2010; 6 2010; 9 2014; 124 2006; 91 2015; 6 2007; 282 2012; 1823 2015; 11 2015; 10 2011; 31 2008; 13 2010; 285 2013; 220 2012; 423 2012; 226 2012; 32 2011; 7 2012; 31 2014; 44 2001; 20 2016; 12 2011; 9 2008; 181 1995; 86 2016; 7 2012; 3 2016; 2 2012; 1 1989; 246 2015; 62 2013; 34 2007; 110 2015; 22 2013; 139 2011; 42 2005; 5 2016; 21 2013; 495 2009; 5 2009; 4 2008; 132 2014; 33 2012; 8 2012; 9 KW Kim (219_CR83) 2008; 4 GMA Ajabnoor (219_CR55) 2012; 3 N Zhang (219_CR64) 2010; 6 R Singh (219_CR25) 2011; 13 SK König (219_CR43) 2010; 65 JR Li (219_CR81) 2013; 220 N Xu (219_CR53) 2012; 423 XM Wan (219_CR95) 2011; 129 HL Chiang (219_CR5) 1989; 246 HX Yuan (219_CR27) 2013; 9 JH Ahn (219_CR66) 2011; 310 DR Camidge (219_CR38) 2014; 11 P Boya (219_CR1) 2013; 15 S Meschini (219_CR75) 2008; 4 A Vazquez-Martin (219_CR58) 2009; 4 CS Wilson (219_CR34) 2001; 14 R Mathew (219_CR47) 2007; 7 S Alers (219_CR26) 2012; 32 W Shuhua (219_CR48) 2015; 46 TR O’Donovan (219_CR61) 2011; 7 BZ Pan (219_CR51) 2014; 13 YJ Lee (219_CR77) 2012; 9 T Hu (219_CR78) 2015; 22 P Kumar (219_CR9) 2012; 1 Y Fujioka (219_CR22) 2010; 285 BYK Law (219_CR86) 2016; 7 LH Zhang (219_CR62) 2016; 21 LY Chiu (219_CR80) 2015; 10 JH Ren (219_CR69) 2010; 25 T Hara (219_CR14) 2008; 181 Y An (219_CR60) 2015; 6 SY Chun (219_CR30) 2015; 72 YJ Wang (219_CR45) 2014; 6 KM Giacomini (219_CR31) 2010; 9 JS Carew (219_CR67) 2007; 110 SW Shin (219_CR63) 2012; 1823 A Khurana (219_CR88) 2015; 6 S Sridhar (219_CR4) 2012; 226 LC Yang (219_CR50) 2012; 29 EYW Chan (219_CR13) 2007; 282 MA Aznar (219_CR79) 2014; 11 ZY Wang (219_CR84) 2014; 5 C Puri (219_CR20) 2013; 154 P Wei (219_CR94) 2010; 21 X Deschenes-Simard (219_CR2) 2014; 13 L Ge (219_CR18) 2013; 2 UM Nazim (219_CR91) 2016; 7 DJ Klionsky (219_CR10) 2012; 8 RH Shoemaker (219_CR36) 2000; 92 GN Zhang (219_CR46) 2015; 34 A Bedi (219_CR35) 1995; 86 XY Jiao (219_CR54) 2013; 139 TT Fan (219_CR52) 2014; 4 DJ Kong (219_CR85) 2012; 66 IG Ganley (219_CR11) 2011; 42 C Rodriguez-Antona (219_CR33) 2006; 25 B Sirichanchuen (219_CR82) 2012; 364 CS Morrow (219_CR42) 2006; 69 WL Sun (219_CR57) 2011; 7 M Hamasaki (219_CR19) 2013; 495 N Mizushima (219_CR21) 1998; 395 K Suzuki (219_CR12) 2001; 20 B Liang (219_CR72) 2016; 82 GM Fimia (219_CR17) 2011; 7 L Yu (219_CR29) 2010; 465 MA Qadir (219_CR56) 2008; 112 X Li (219_CR87) 2016; 12 C Shi (219_CR70) 2015; 495 WJ Buchser (219_CR7) 2012; 72 J Romanov (219_CR23) 2012; 31 N Anreddy (219_CR44) 2014; 19 A Isakovic (219_CR92) 2006; 91 WL Sun (219_CR59) 2015; 62 L Milane (219_CR39) 2011; 11 G Filomeni (219_CR32) 2008; 7 KJ Park (219_CR89) 2007; 67 B Levine (219_CR3) 2008; 132 K Obara (219_CR15) 2008; 13 B Pasquier (219_CR28) 2015; 11 C Kaewpiboon (219_CR90) 2014; 44 Q Zhang (219_CR93) 2009; 5 H Li (219_CR37) 2013; 34 S Chittaranjan (219_CR76) 2014; 20 XH Ma (219_CR68) 2014; 124 RJ Kathawala (219_CR41) 2014; 33 K Matsunaga (219_CR16) 2009; 11 QW Fan (219_CR65) 2010; 3 P Hundeshagen (219_CR6) 2011; 9 C Holohan (219_CR8) 2013; 13 KH Eum (219_CR73) 2011; 31 M Dean (219_CR40) 2005; 5 Y Ichimura (219_CR24) 2000; 408 M Yang (219_CR49) 2014; 9 M Gao (219_CR71) 2016; 2 J Ge (219_CR74) 2014; 9 |
| References_xml | – volume: 220 start-page: 267 issue: 3 year: 2013 end-page: 276 article-title: Dual inhibitor of phosphoinositide 3‐kinase/mammalian target of rapamycin NVP‐BEZ235 effectively inhibits cisplatin‐resistant urothelial cancer cell growth through autophagic flux publication-title: Toxicol Lett – volume: 181 start-page: 497 issue: 3 year: 2008 end-page: 510 article-title: FIP200, a ULK‐interacting protein, is required for autophagosome formation in mammalian cells publication-title: J Cell Biol. – volume: 110 start-page: 313 issue: 1 year: 2007 end-page: 322 article-title: Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr‐Abl‐mediated drug resistance publication-title: Blood – volume: 226 start-page: 255 issue: 2 year: 2012 end-page: 273 article-title: Autophagy and disease: always two sides to a problem publication-title: J Pathol – volume: 34 start-page: 870 issue: 7 year: 2013 end-page: 879 article-title: Friend or foe: the role of microRNA in chemotherapy resistance publication-title: Acta Pharmacol Sin – volume: 20 start-page: 5971 issue: 21 year: 2001 end-page: 5981 article-title: The pre‐autophagosomal structure organized by concerted functions of APG genes is essential for autophagosome formation publication-title: EMBO J. – volume: 124 start-page: 1406 issue: 3 year: 2014 end-page: 1417 article-title: Targeting ER stress‐induced autophagy overcomes BRAF inhibitor resistance in melanoma publication-title: J Clin Investig – volume: 19 start-page: 13848 issue: 9 year: 2014 end-page: 13877 article-title: Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance publication-title: Molecules – volume: 7 start-page: 1035 issue: 9 year: 2011 end-page: 1044 article-title: Autophagy protects breast cancer cells from epirubicin‐induced apoptosis and facilitates epirubicin‐resistance development publication-title: Autophagy – volume: 11 start-page: 385 issue: 4 year: 2009 end-page: 396 article-title: Two Beclin 1‐binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages publication-title: Nat Cell Biol. – volume: 3 start-page: 81 issue: 147 year: 2010 article-title: Akt and autophagy cooperate to promote survival of drug‐resistant glioma publication-title: Sci Signal – volume: 32 start-page: 2 issue: 1 year: 2012 end-page: 11 article-title: Role of AMPK‐mTOR‐Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks publication-title: Mol Cell Biol. – volume: 9 start-page: 1983 issue: 12 year: 2013 end-page: 1995 article-title: Regulation of PIK3C3/VPS34 complexes by MTOR in nutrient stress‐induced autophagy publication-title: Autophagy – volume: 4 start-page: 49 year: 2014 article-title: Peptidylarginine deiminase IV promotes the development of chemoresistance through inducing autophagy in hepatocellular carcinoma publication-title: Cell Biosci – volume: 2 year: 2013 article-title: The ER‐Golgi intermediate compartment is a key membrane source for the LC3 lipidation step of autophagosome biogenesis publication-title: Elife – volume: 6 start-page: 1157 issue: 8 year: 2010 end-page: 1167 article-title: FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: a protective role of autophagy publication-title: Autophagy – volume: 7 start-page: 8090 issue: 7 year: 2016 end-page: 8104 article-title: Hernandezine, a novel AMPK activator induces autophagic cell death in drug‐resistant cancers publication-title: Oncotarget – volume: 11 start-page: 725 issue: 4 year: 2015 article-title: SAR405, a PIK3C3/Vps34 inhibitor that prevents autophagy and synergizes with MTOR inhibition in tumor cells publication-title: Autophagy – volume: 1 start-page: 558 issue: 3 year: 2012 end-page: 575 article-title: Autophagy and transporter‐based multi‐drug resistance publication-title: Cells – volume: 310 start-page: 188 issue: 2 year: 2011 end-page: 197 article-title: Suppression of autophagy sensitizes multidrug resistant cells towards Src tyrosine kinase specific inhibitor PP2 publication-title: Cancer Lett – volume: 44 start-page: 1233 issue: 4 year: 2014 end-page: 1242 article-title: Feroniellin A‐induced autophagy causes apoptosis in multidrug‐resistant human A549 lung cancer cells publication-title: Int J Oncol. – volume: 7 start-page: 509 issue: 5 year: 2011 end-page: 524 article-title: Induction of autophagy by drug‐resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics publication-title: Autophagy – volume: 8 start-page: 1281 issue: 9 year: 2012 end-page: 1282 article-title: Look people, “Atg” is an abbreviation for “autophagy‐related.” That's it publication-title: Autophagy – volume: 31 start-page: 231 issue: 3 year: 2011 end-page: 238 article-title: Targeting the autophagy pathway using ectopic expression of Beclin 1 in combination with rapamycin in drug‐resistant v‐Ha‐ras‐transformed NIH3T3 cells publication-title: Mol Cells – volume: 10 issue: 5 year: 2015 article-title: Immunomodulatory protein from Ganoderma microsporum induces pro‐death autophagy through Akt‐mTOR‐p70S6K pathway inhibition in multidrug resistant lung cancer cells publication-title: PLoS ONE – volume: 5 start-page: 7013 issue: 16 year: 2014 end-page: 7026 article-title: MicroRNA‐25 regulates chemoresistance‐associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin publication-title: Oncotarget – volume: 31 start-page: 4304 issue: 22 year: 2012 end-page: 4317 article-title: Mechanism and functions of membrane binding by the Atg5‐Atg12/Atg16 complex during autophagosome formation publication-title: EMBO J. – volume: 25 start-page: 1679 issue: 11 year: 2006 end-page: 1691 article-title: Cytochrome P450 pharmacogenetics and cancer publication-title: Oncogene – volume: 34 start-page: 1 issue: 3 year: 2015 article-title: The reversal of antineoplastic drug resistance in cancer cells by β‐elemene publication-title: Chin J Cancer – volume: 1823 start-page: 451 issue: 2 year: 2012 end-page: 457 article-title: Autophagy inhibition enhances ursolic acid‐induced apoptosis in PC3 cells publication-title: BBA‐Mol Cell Res. – volume: 13 start-page: 537 issue: 6 year: 2008 end-page: 547 article-title: Transport of phosphatidylinositol 3‐phosphate into the vacuole via autophagic membranes in publication-title: Genes Cells – volume: 129 start-page: 1087 issue: 5 year: 2011 end-page: 1095 article-title: Autophagy‐mediated chemosensitization by cysteamine in cancer cells publication-title: Int J Cancer – volume: 13 start-page: 495 issue: 5 year: 2011 end-page: 504 article-title: Autophagy in the cellular energetic balance publication-title: Cell Metab – volume: 7 start-page: 961 issue: 12 year: 2007 end-page: 967 article-title: Role of autophagy in cancer publication-title: Nat Rev Cancer – volume: 67 start-page: 7327 issue: 15 year: 2007 end-page: 7334 article-title: A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL‐sensitive and TRAIL‐resistant cancer cells publication-title: Cancer Res. – volume: 364 start-page: 11 issue: 1–2 year: 2012 end-page: 18 article-title: Long‐term cisplatin exposure impairs autophagy and causes cisplatin resistance in human lung cancer cells publication-title: Mol Cell Biochem – volume: 9 start-page: 215 issue: 3 year: 2010 end-page: 236 article-title: Membrane transporters in drug development publication-title: Nat Rev Drug Discov – volume: 86 start-page: 1148 issue: 3 year: 1995 end-page: 1158 article-title: BCR‐ABL‐mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents publication-title: Blood – volume: 6 start-page: 1925 issue: 4 year: 2014 article-title: Repositioning of tyrosine kinase inhibitors as antagonists of ATP‐binding cassette transporters in anticancer drug resistance publication-title: Cancers – volume: 495 start-page: 932 issue: 2 year: 2015 end-page: 939 article-title: Co‐delivery of docetaxel and chloroquine via PEO–PPO–PCL/TPGS micelles for overcoming multidrug resistance publication-title: Int J Pharm – volume: 4 start-page: 1020 issue: 8 year: 2008 end-page: 1033 article-title: The plant alkaloid voacamine induces apoptosis‐independent autophagic cell death on both sensitive and multidrug resistant human osteosarcoma cells publication-title: Autophagy – volume: 11 start-page: 473 issue: 8 year: 2014 end-page: 481 article-title: Acquired resistance to TKIs in solid tumours: learning from lung cancer publication-title: Nat Rev Clin Oncol. – volume: 11 start-page: 3 year: 2011 article-title: Role of hypoxia and glycolysis in the development of multi‐drug resistance in human tumor cells and the establishment of an orthotopic multi‐drug resistant tumor model in nude mice using hypoxic pre‐conditioning publication-title: Cancer Cell Int – volume: 21 start-page: 473 issue: 4 year: 2016 end-page: 488 article-title: Enhanced autophagy reveals vulnerability of P‐gp mediated epirubicin resistance in triple negative breast cancer cells publication-title: Apoptosis – volume: 72 start-page: 37 year: 2015 end-page: 43 article-title: Lapatinib enhances the cytotoxic effects of doxorubicin in MCF‐7 tumorspheres by inhibiting the drug efflux function of ABC transporters publication-title: Biomed Pharmacother – volume: 5 start-page: 275 issue: 4 year: 2005 end-page: 284 article-title: Tumour stem cells and drug resistance publication-title: Nat Rev Cancer – volume: 25 start-page: 75 issue: 1 year: 2010 end-page: 80 article-title: Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy publication-title: Cancer Biother Radiopharm – volume: 6 start-page: 36354 issue: 34 year: 2015 end-page: 36369 article-title: Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth publication-title: Oncotarget – volume: 154 start-page: 1285 issue: 6 year: 2013 end-page: 1299 article-title: Diverse autophagosome membrane sources coalesce in recycling endosomes publication-title: Cell – volume: 14 start-page: 886 issue: 9 year: 2001 end-page: 891 article-title: DNA topoisomerase II alpha in multiple myeloma: a marker of cell proliferation and not drug resistance publication-title: Mod Pathol – volume: 22 start-page: 536 issue: 5 year: 2015 end-page: 544 article-title: Sensitivity of apoptosis‐resistant colon cancer cells to tanshinones is mediated by autophagic cell death and p53‐independent cytotoxicity publication-title: Phytomedicine – volume: 408 start-page: 488 issue: 6811 year: 2000 end-page: 492 article-title: A ubiquitin‐like system mediates protein lipidation publication-title: Nature – volume: 72 start-page: 2970 issue: 12 year: 2012 end-page: 2979 article-title: Cell‐mediated autophagy promotes cancer cell survival publication-title: Cancer Res. – volume: 9 issue: 5 year: 2014 article-title: S100A8 contributes to drug resistance by promoting autophagy in leukemia cells publication-title: PLoS ONE – volume: 495 start-page: 389 issue: 7441 year: 2013 end-page: 393 article-title: Autophagosomes form at ER‐mitochondria contact sites publication-title: Nature – volume: 91 start-page: 173 issue: 1 year: 2006 end-page: 183 article-title: Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene publication-title: Toxicol Sci. – volume: 4 issue: 7 year: 2009 article-title: Autophagy facilitates the development of breast cancer resistance to the anti‐HER2 monoclonal antibody trastuzumab publication-title: PLoS ONE – volume: 20 start-page: 3159 issue: 12 year: 2014 end-page: 3173 article-title: Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline‐sensitive and ‐resistant triple‐negative breast cancer publication-title: Clin Cancer Res. – volume: 7 start-page: 23468 issue: 17 year: 2016 end-page: 23481 article-title: Activation of autophagy flux by metformin downregulates cellular FLICE‐like inhibitory protein and enhances TRAIL‐induced apoptosis publication-title: Oncotarget – volume: 2 start-page: 1 year: 2016 end-page: 10 article-title: Sensitization of multidrug‐resistant malignant cells by liposomes co‐encapsulating doxorubicin and chloroquine through autophagic inhibition publication-title: J Liposome Res. – volume: 21 issue: 49 year: 2010 article-title: C60(Nd) nanoparticles enhance chemotherapeutic susceptibility of cancer cells by modulation of autophagy publication-title: Nanotechnology – volume: 13 start-page: 165 year: 2014 article-title: HMGB1‐mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma publication-title: Mol Cancer – volume: 282 start-page: 25464 issue: 35 year: 2007 end-page: 25474 article-title: SiRNA screening of the kinome identifies ULK1 as a multidomain modulator of autophagy publication-title: J Biol Chem. – volume: 4 start-page: 659 issue: 5 year: 2008 end-page: 668 article-title: Autophagy upregulation by inhibitors of caspase‐3 and mTOR enhances radiotherapy in a mouse model of lung cancer publication-title: Autophagy – volume: 285 start-page: 1508 issue: 2 year: 2010 end-page: 1515 article-title: Dimeric coiled‐coil structure of Atg16 and its functional significance in autophagy publication-title: J Biol Chem. – volume: 29 start-page: 65 issue: 1 year: 2012 end-page: 72 article-title: S100A8‐targeting siRNA enhances arsenic trioxide‐induced myeloid leukemia cell death by down‐regulating autophagy publication-title: Int J Mol Med. – volume: 6 year: 2015 article-title: miR‐23b‐3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2 publication-title: Cell Death Dis – volume: 7 start-page: 115 issue: 1 year: 2011 end-page: 117 article-title: Unleashing the Ambra1‐Beclin 1 complex from dynein chains Ulk1 sets Ambra1 free to induce autophagy publication-title: Autophagy – volume: 15 start-page: 713 issue: 8 year: 2013 end-page: 720 article-title: Emerging regulation and functions of autophagy publication-title: Nat Cell Biol. – volume: 12 start-page: 948 issue: 5 year: 2016 end-page: 961 article-title: Quaternized chitosan/alginate‐Fe3O4 magnetic nanoparticles enhance the chemosensitization of multidrug‐resistant gastric carcinoma by regulating cell autophagy activity in mice publication-title: J Biomed Nanotechnol – volume: 5 start-page: 1107 issue: 8 year: 2009 end-page: 1117 article-title: Autophagy‐mediated chemosensitization in cancer cells by fullerene C60 nanocrystal publication-title: Autophagy – volume: 246 start-page: 382 issue: 4928 year: 1989 end-page: 385 article-title: A role for a 70‐kilodalton heat shock protein in lysosomal degradation of intracellular proteins publication-title: Science – volume: 132 start-page: 27 issue: 1 year: 2008 end-page: 42 article-title: Autophagy in the pathogenesis of disease publication-title: Cell – volume: 395 start-page: 395 issue: 6700 year: 1998 end-page: 398 article-title: A protein conjugation system essential for autophagy publication-title: Nature – volume: 3 year: 2012 article-title: Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF‐7 breast cancer cells publication-title: Cell Death Dis – volume: 9 issue: 10 year: 2014 article-title: Upregulation of autophagy‐related gene‐5 (ATG‐5) is associated with chemoresistance in human gastric cancer publication-title: PLoS ONE – volume: 139 start-page: 717 issue: 3 year: 2013 end-page: 730 article-title: MiR‐181a enhances drug sensitivity in mitoxantone‐resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2) publication-title: Breast Cancer Res Treat – volume: 13 start-page: 714 issue: 10 year: 2013 end-page: 726 article-title: Cancer drug resistance: an evolving paradigm publication-title: Nat Rev Cancer – volume: 112 start-page: 389 issue: 3 year: 2008 end-page: 403 article-title: Macroautophagy inhibition sensitizes tamoxifen‐resistant breast cancer cells and enhances mitochondrial depolarization publication-title: Breast Cancer Res Treat – volume: 13 start-page: 1840 issue: 12 year: 2014 end-page: 1858 article-title: Cellular senescence and protein degradation breaking down cancer publication-title: Cell Cycle – volume: 65 start-page: 2319 issue: 11 year: 2010 end-page: 2328 article-title: Impact of drug transporters on cellular resistance towards saquinavir and darunavir publication-title: J Antimicrob Chemother – volume: 69 start-page: 1499 issue: 4 year: 2006 end-page: 1505 article-title: Multidrug resistance protein 1 (MRP1, ABCC1) mediates resistance to mitoxantrone via glutathione‐dependent drug efflux publication-title: Mol Pharmacol – volume: 66 start-page: 271 issue: 4 year: 2012 end-page: 278 article-title: The different regulatory effects of p53 status on multidrug resistance are determined by autophagy in ovarian cancer cells publication-title: Biomed Pharmacother – volume: 42 start-page: 731 issue: 6 year: 2011 end-page: 743 article-title: Distinct autophagosomal‐lysosomal fusion mechanism revealed by thapsigargin‐induced autophagy arrest publication-title: Mol Cell – volume: 423 start-page: 826 issue: 4 year: 2012 end-page: 831 article-title: Cisplatin‐induced downregulation of miR‐199a‐5p increases drug resistance by activating autophagy in HCC cell publication-title: Biochem Biophys Res Commun – volume: 7 start-page: 371 issue: 2 year: 2008 end-page: 379 article-title: 6‐(7‐Nitro‐2,1,3‐benzoxadiazol‐4‐ylthio)hexanol, a specific glutathione S‐transferase inhibitor, overcomes the multidrug resistance (MDR)‐associated protein 1‐mediated MDR in small cell lung cancer publication-title: Mol Cancer Ther – volume: 33 start-page: 223 issue: 5 year: 2014 end-page: 230 article-title: Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs publication-title: Chin J Cancer – volume: 46 start-page: 1752 issue: 11 year: 2015 end-page: 1759 article-title: Autophagy‐related genes Raptor, Rictor, and Beclin1 expression and relationship with multidrug resistance in colorectal carcinoma publication-title: Hum Pathol – volume: 82 start-page: 98 year: 2016 end-page: 105 article-title: Inhibition of autophagy sensitizes MDR‐phenotype ovarian cancer SKVCR cells to chemotherapy publication-title: Biomed Pharmacother – volume: 9 start-page: 881 issue: 10 year: 2012 end-page: 893 article-title: Molecular mechanism of SAHA on regulation of autophagic cell death in tamoxifen‐resistant MCF‐7 breast cancer cells publication-title: Int J Med Sci. – volume: 92 start-page: 4 issue: 1 year: 2000 end-page: 5 article-title: Genetic and epigenetic factors in anticancer drug resistance publication-title: J Natl Cancer Inst. – volume: 11 start-page: 2650 issue: 8 year: 2014 end-page: 2658 article-title: Edelfosine lipid nanoparticles overcome multidrug resistance in K‐562 leukemia cells by a caspase‐independent mechanism publication-title: Mol Pharm – volume: 9 start-page: 38 year: 2011 article-title: Concurrent detection of autolysosome formation and lysosomal degradation by flow cytometry in a high‐content screen for inducers of autophagy publication-title: BMC Biol. – volume: 465 start-page: 942 issue: 7300 year: 2010 end-page: 946 article-title: Termination of autophagy and reformation of lysosomes regulated by mTOR publication-title: Nature – volume: 62 start-page: 199 issue: 2 year: 2015 end-page: 208 article-title: Autophagy facilitates multidrug resistance development through inhibition of apoptosis in breast cancer cells publication-title: Neoplasma – volume: 154 start-page: 1285 issue: 6 year: 2013 ident: 219_CR20 publication-title: Cell doi: 10.1016/j.cell.2013.08.044 – volume: 10 start-page: e0125774 issue: 5 year: 2015 ident: 219_CR80 publication-title: PLoS ONE doi: 10.1371/journal.pone.0125774 – volume: 7 start-page: 115 issue: 1 year: 2011 ident: 219_CR17 publication-title: Autophagy doi: 10.4161/auto.7.1.14071 – volume: 6 start-page: 36354 issue: 34 year: 2015 ident: 219_CR88 publication-title: Oncotarget doi: 10.18632/oncotarget.5632 – volume: 408 start-page: 488 issue: 6811 year: 2000 ident: 219_CR24 publication-title: Nature doi: 10.1038/35044114 – volume: 3 start-page: e260 year: 2012 ident: 219_CR55 publication-title: Cell Death Dis doi: 10.1038/cddis.2011.139 – volume: 14 start-page: 886 issue: 9 year: 2001 ident: 219_CR34 publication-title: Mod Pathol doi: 10.1038/modpathol.3880407 – volume: 4 start-page: e6251 issue: 7 year: 2009 ident: 219_CR58 publication-title: PLoS ONE doi: 10.1371/journal.pone.0006251 – volume: 25 start-page: 1679 issue: 11 year: 2006 ident: 219_CR33 publication-title: Oncogene doi: 10.1038/sj.onc.1209377 – volume: 20 start-page: 3159 issue: 12 year: 2014 ident: 219_CR76 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-13-2060 – volume: 9 start-page: e97242 issue: 5 year: 2014 ident: 219_CR49 publication-title: PLoS ONE doi: 10.1371/journal.pone.0097242 – volume: 129 start-page: 1087 issue: 5 year: 2011 ident: 219_CR95 publication-title: Int J Cancer doi: 10.1002/ijc.25771 – volume: 25 start-page: 75 issue: 1 year: 2010 ident: 219_CR69 publication-title: Cancer Biother Radiopharm doi: 10.1089/cbr.2009.0701 – volume: 13 start-page: 165 year: 2014 ident: 219_CR51 publication-title: Mol Cancer doi: 10.1186/1476-4598-13-165 – volume: 495 start-page: 932 issue: 2 year: 2015 ident: 219_CR70 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2015.10.009 – volume: 5 start-page: 1107 issue: 8 year: 2009 ident: 219_CR93 publication-title: Autophagy doi: 10.4161/auto.5.8.9842 – volume: 6 start-page: 1157 issue: 8 year: 2010 ident: 219_CR64 publication-title: Autophagy doi: 10.4161/auto.6.8.13614 – volume: 124 start-page: 1406 issue: 3 year: 2014 ident: 219_CR68 publication-title: J Clin Investig doi: 10.1172/JCI70454 – volume: 13 start-page: 537 issue: 6 year: 2008 ident: 219_CR15 publication-title: Genes Cells doi: 10.1111/j.1365-2443.2008.01188.x – volume: 66 start-page: 271 issue: 4 year: 2012 ident: 219_CR85 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2011.12.002 – volume: 395 start-page: 395 issue: 6700 year: 1998 ident: 219_CR21 publication-title: Nature doi: 10.1038/26506 – volume: 7 start-page: 1035 issue: 9 year: 2011 ident: 219_CR57 publication-title: Autophagy doi: 10.4161/auto.7.9.16521 – volume: 4 start-page: 659 issue: 5 year: 2008 ident: 219_CR83 publication-title: Autophagy doi: 10.4161/auto.6058 – volume: 86 start-page: 1148 issue: 3 year: 1995 ident: 219_CR35 publication-title: Blood doi: 10.1182/blood.V86.3.1148.1148 – volume: 7 start-page: 961 issue: 12 year: 2007 ident: 219_CR47 publication-title: Nat Rev Cancer doi: 10.1038/nrc2254 – volume: 21 start-page: 495101 issue: 49 year: 2010 ident: 219_CR94 publication-title: Nanotechnology doi: 10.1088/0957-4484/21/49/495101 – volume: 4 start-page: 1020 issue: 8 year: 2008 ident: 219_CR75 publication-title: Autophagy doi: 10.4161/auto.6952 – volume: 19 start-page: 13848 issue: 9 year: 2014 ident: 219_CR44 publication-title: Molecules doi: 10.3390/molecules190913848 – volume: 9 start-page: 38 year: 2011 ident: 219_CR6 publication-title: BMC Biol doi: 10.1186/1741-7007-9-38 – volume: 11 start-page: 385 issue: 4 year: 2009 ident: 219_CR16 publication-title: Nat Cell Biol doi: 10.1038/ncb1846 – volume: 110 start-page: 313 issue: 1 year: 2007 ident: 219_CR67 publication-title: Blood doi: 10.1182/blood-2006-10-050260 – volume: 42 start-page: 731 issue: 6 year: 2011 ident: 219_CR11 publication-title: Mol Cell doi: 10.1016/j.molcel.2011.04.024 – volume: 13 start-page: 495 issue: 5 year: 2011 ident: 219_CR25 publication-title: Cell Metab doi: 10.1016/j.cmet.2011.04.004 – volume: 69 start-page: 1499 issue: 4 year: 2006 ident: 219_CR42 publication-title: Mol Pharmacol doi: 10.1124/mol.105.017988 – volume: 34 start-page: 870 issue: 7 year: 2013 ident: 219_CR37 publication-title: Acta Pharmacol Sin doi: 10.1038/aps.2013.35 – volume: 44 start-page: 1233 issue: 4 year: 2014 ident: 219_CR90 publication-title: Int J Oncol doi: 10.3892/ijo.2014.2297 – volume: 246 start-page: 382 issue: 4928 year: 1989 ident: 219_CR5 publication-title: Science doi: 10.1126/science.2799391 – volume: 8 start-page: 1281 issue: 9 year: 2012 ident: 219_CR10 publication-title: Autophagy doi: 10.4161/auto.21812 – volume: 9 start-page: 881 issue: 10 year: 2012 ident: 219_CR77 publication-title: Int J Med Sci doi: 10.7150/ijms.5011 – volume: 423 start-page: 826 issue: 4 year: 2012 ident: 219_CR53 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2012.06.048 – volume: 62 start-page: 199 issue: 2 year: 2015 ident: 219_CR59 publication-title: Neoplasma doi: 10.4149/neo_2015_025 – volume: 11 start-page: 2650 issue: 8 year: 2014 ident: 219_CR79 publication-title: Mol Pharm doi: 10.1021/mp5000696 – volume: 11 start-page: 725 issue: 4 year: 2015 ident: 219_CR28 publication-title: Autophagy doi: 10.1080/15548627.2015.1033601 – volume: 6 start-page: e1766 year: 2015 ident: 219_CR60 publication-title: Cell Death Dis doi: 10.1038/cddis.2015.123 – volume: 21 start-page: 473 issue: 4 year: 2016 ident: 219_CR62 publication-title: Apoptosis doi: 10.1007/s10495-016-1214-9 – volume: 11 start-page: 3 year: 2011 ident: 219_CR39 publication-title: Cancer Cell Int doi: 10.1186/1475-2867-11-3 – volume: 72 start-page: 2970 issue: 12 year: 2012 ident: 219_CR7 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-11-3396 – volume: 91 start-page: 173 issue: 1 year: 2006 ident: 219_CR92 publication-title: Toxicol Sci doi: 10.1093/toxsci/kfj127 – volume: 282 start-page: 25464 issue: 35 year: 2007 ident: 219_CR13 publication-title: J Biol Chem doi: 10.1074/jbc.M703663200 – volume: 226 start-page: 255 issue: 2 year: 2012 ident: 219_CR4 publication-title: J Pathol doi: 10.1002/path.3025 – volume: 72 start-page: 37 year: 2015 ident: 219_CR30 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2015.03.009 – volume: 92 start-page: 4 issue: 1 year: 2000 ident: 219_CR36 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/92.1.4 – volume: 132 start-page: 27 issue: 1 year: 2008 ident: 219_CR3 publication-title: Cell doi: 10.1016/j.cell.2007.12.018 – volume: 9 start-page: 1983 issue: 12 year: 2013 ident: 219_CR27 publication-title: Autophagy doi: 10.4161/auto.26058 – volume: 364 start-page: 11 issue: 1–2 year: 2012 ident: 219_CR82 publication-title: Mol Cell Biochem doi: 10.1007/s11010-011-1199-1 – volume: 7 start-page: 509 issue: 5 year: 2011 ident: 219_CR61 publication-title: Autophagy doi: 10.4161/auto.7.5.15066 – volume: 82 start-page: 98 year: 2016 ident: 219_CR72 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2016.04.054 – volume: 22 start-page: 536 issue: 5 year: 2015 ident: 219_CR78 publication-title: Phytomedicine doi: 10.1016/j.phymed.2015.03.010 – volume: 9 start-page: 215 issue: 3 year: 2010 ident: 219_CR31 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd3028 – volume: 7 start-page: 371 issue: 2 year: 2008 ident: 219_CR32 publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-07-0487 – volume: 5 start-page: 7013 issue: 16 year: 2014 ident: 219_CR84 publication-title: Oncotarget doi: 10.18632/oncotarget.2192 – volume: 285 start-page: 1508 issue: 2 year: 2010 ident: 219_CR22 publication-title: J Biol Chem doi: 10.1074/jbc.M109.053520 – volume: 32 start-page: 2 issue: 1 year: 2012 ident: 219_CR26 publication-title: Mol Cell Biol doi: 10.1128/MCB.06159-11 – volume: 20 start-page: 5971 issue: 21 year: 2001 ident: 219_CR12 publication-title: EMBO J doi: 10.1093/emboj/20.21.5971 – volume: 7 start-page: 23468 issue: 17 year: 2016 ident: 219_CR91 publication-title: Oncotarget doi: 10.18632/oncotarget.8048 – volume: 11 start-page: 473 issue: 8 year: 2014 ident: 219_CR38 publication-title: Nat Rev Clin Oncol doi: 10.1038/nrclinonc.2014.104 – volume: 15 start-page: 713 issue: 8 year: 2013 ident: 219_CR1 publication-title: Nat Cell Biol doi: 10.1038/ncb2788 – volume: 67 start-page: 7327 issue: 15 year: 2007 ident: 219_CR89 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-4766 – volume: 29 start-page: 65 issue: 1 year: 2012 ident: 219_CR50 publication-title: Int J Mol Med doi: 10.3892/ijmm.2011.806 – volume: 2 start-page: 00947 year: 2013 ident: 219_CR18 publication-title: Elife doi: 10.7554/eLife.00947 – volume: 495 start-page: 389 issue: 7441 year: 2013 ident: 219_CR19 publication-title: Nature doi: 10.1038/nature11910 – volume: 46 start-page: 1752 issue: 11 year: 2015 ident: 219_CR48 publication-title: Hum Pathol doi: 10.1016/j.humpath.2015.07.016 – volume: 31 start-page: 231 issue: 3 year: 2011 ident: 219_CR73 publication-title: Mol Cells doi: 10.1007/s10059-011-0034-6 – volume: 465 start-page: 942 issue: 7300 year: 2010 ident: 219_CR29 publication-title: Nature doi: 10.1038/nature09076 – volume: 5 start-page: 275 issue: 4 year: 2005 ident: 219_CR40 publication-title: Nat Rev Cancer doi: 10.1038/nrc1590 – volume: 33 start-page: 223 issue: 5 year: 2014 ident: 219_CR41 publication-title: Chin J Cancer doi: 10.5732/cjc.013.10122 – volume: 310 start-page: 188 issue: 2 year: 2011 ident: 219_CR66 publication-title: Cancer Lett doi: 10.1016/j.canlet.2011.06.034 – volume: 65 start-page: 2319 issue: 11 year: 2010 ident: 219_CR43 publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkq324 – volume: 220 start-page: 267 issue: 3 year: 2013 ident: 219_CR81 publication-title: Toxicol Lett doi: 10.1016/j.toxlet.2013.04.021 – volume: 3 start-page: 81 issue: 147 year: 2010 ident: 219_CR65 publication-title: Sci Signal doi: 10.1126/scisignal.2001017 – volume: 9 start-page: e110293 issue: 10 year: 2014 ident: 219_CR74 publication-title: PLoS ONE doi: 10.1371/journal.pone.0110293 – volume: 4 start-page: 49 year: 2014 ident: 219_CR52 publication-title: Cell Biosci doi: 10.1186/2045-3701-4-49 – volume: 7 start-page: 8090 issue: 7 year: 2016 ident: 219_CR86 publication-title: Oncotarget doi: 10.18632/oncotarget.6980 – volume: 34 start-page: 1 issue: 3 year: 2015 ident: 219_CR46 publication-title: Chin J Cancer doi: 10.1186/s40880-015-0006-x – volume: 1823 start-page: 451 issue: 2 year: 2012 ident: 219_CR63 publication-title: BBA-Mol Cell Res doi: 10.1016/j.bbamcr.2011.10.014 – volume: 13 start-page: 1840 issue: 12 year: 2014 ident: 219_CR2 publication-title: Cell Cycle doi: 10.4161/cc.29335 – volume: 1 start-page: 558 issue: 3 year: 2012 ident: 219_CR9 publication-title: Cells doi: 10.3390/cells1030558 – volume: 112 start-page: 389 issue: 3 year: 2008 ident: 219_CR56 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-007-9873-4 – volume: 6 start-page: 1925 issue: 4 year: 2014 ident: 219_CR45 publication-title: Cancers doi: 10.3390/cancers6041925 – volume: 31 start-page: 4304 issue: 22 year: 2012 ident: 219_CR23 publication-title: EMBO J doi: 10.1038/emboj.2012.278 – volume: 12 start-page: 948 issue: 5 year: 2016 ident: 219_CR87 publication-title: J Biomed Nanotechnol doi: 10.1166/jbn.2016.2232 – volume: 2 start-page: 1 year: 2016 ident: 219_CR71 publication-title: J Liposome Res doi: 10.1080/08982104.2016.1185731 – volume: 181 start-page: 497 issue: 3 year: 2008 ident: 219_CR14 publication-title: J Cell Biol doi: 10.1083/jcb.200712064 – volume: 139 start-page: 717 issue: 3 year: 2013 ident: 219_CR54 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-013-2607-x – volume: 13 start-page: 714 issue: 10 year: 2013 ident: 219_CR8 publication-title: Nat Rev Cancer doi: 10.1038/nrc3599 |
| SSID | ssj0041978 ssj0001989453 |
| Score | 2.60393 |
| SecondaryResourceType | review_article |
| Snippet | Multidrug resistance (MDR) occurs frequently after long-term chemotherapy, resulting in refractory cancer and tumor recurrence. Therefore, combatting MDR is an... Multidrug resistance (MDR) occurs frequently after long‐term chemotherapy, resulting in refractory cancer and tumor recurrence. Therefore, combatting MDR is an... Multidrug resistance (MDR) occurs frequently after long-term chemotherapy,resulting in refractory cancer and tumor recurrence.Therefore,combatting MDR is an... Abstract Multidrug resistance (MDR) occurs frequently after long-term chemotherapy, resulting in refractory cancer and tumor recurrence. Therefore, combatting... |
| SourceID | doaj pubmedcentral wanfang proquest gale pubmed crossref wiley chongqing |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 342 |
| SubjectTerms | Amino acids Antineoplastic Agents - therapeutic use Apoptosis Apoptosis - drug effects Autophagy Autophagy (Cytology) Autophagy - drug effects Autophagy - genetics Autophagy;Drug Cancer Cancer therapies Care and treatment Cell death Cell growth Cell survival Chemotherapy death Diagnosis Drug resistance Drug resistance in microorganisms Drug Resistance, Multiple - genetics Drug Resistance, Neoplasm - genetics Endoplasmic reticulum Enzymes Fatty acids Homeostasis Humans Hypoxia Kinases Lung cancer Multidrug resistant organisms Nanoparticles Neoplasms Neoplasms - drug therapy Neoplasms - genetics Neoplasms - pathology Ovarian cancer Proteins Recycling resistance;Neoplasms;Cell Review survival;Cell |
| SummonAdditionalLinks | – databaseName: Open Access资源_DOAJ dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9QwFA6yoPgi6706agVBEMu2aa6-jYPLIqwvurBvIdfZBeno7A6L_nrPSTt1quC--DakJyE9l5zzTdIvhLyiAXKsiqHCTaOK2YZVuk2sCl5BuotS8Ij_dxx_Ekcn7OMpP9256gvPhPX0wL3iDnyAkt55BHEAZVqlEsDuIJSNUDxol5lAIedtwVS_BrMGwNGwh9kocXDBIJjwAJasIKfpiiKTwtmqW36H_DDJSJm4_-_leSc__Xl28uaV7ZLFYXar25yeDvfJnaGuLOf9-9wlN2J3j9w6HnbO75O38w1SCNjlj9J2ocznCMN6sywBbmMJCbYvz7vS44_1A3Jy-OHL4qgabkqovJQNraylbZKJusRTiJ7FaJMQkbOknBYy1FJbql1qvOOt9hQanQLkEVrLg026fUj2ulUXH5PSeQq6AytJ5VlbB6ddrWMNWcsmJltakNmoOfOtZ8Qwsue94VwWpN4q0_iBZRwvu_hqMtpQwvS2MGALg7YwMOKbsct2wH8Iv0cLjYLIjp0bwGfM4DPmOp8pyAu0r-k_NR1j3Mw53nADylIFeZ0lMMph-t4OHyuAjpAvayI5m0hCdPrp460PmWF1uDCAkTleccJ1QV6Oj7Ennnjr4mqTZVoFtZhqCvKod7nxpSnYTkCWKoicOONEK9Mn3flZ5g4HgEq14DCtwW1_zyr-pEimBAiiLci77MvX28Ms5gv6ObdiZ2ijT_6HiZ6S2zSHq6gom5G9y_UmPoPy79I9z5H-C4E1TW8 priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3di9QwEA96Ivgiil_VVSsIglhum48m8UXWxeMQ9EUP9i3kc-9Aune7t4j-9c6k3e5V4XwrySQkmZnMTJL-hpDXNICNVTFUeGlUcVvzSrPEq-AVmLsoGxHxvOPL1-b4hH9eiEV_4Lbpn1Xu9sS8UYeVxzPyQ4grBKaFEPrD-UWFWaPwdrVPoXGT3ELoMpRquZD7MxZEFxesv8ysVXO44aBV-BJLVmDcdEURUuF01S4vwFCMTFNG8P93n75iqP5-RHn7p22TxW6uurnZTh3dI3d7B7OcdRJxn9yI7QPybrZFAAG7_FXaNpT5FWFYb5clBNvoQALny7O29PixfkhOjj59nx9XfZ6EyktZ08paypJM1CWRQvQ8RpuaJgqelNONDFOpLdUu1d4Jpj2FQqcg7gjMimCTZo_IQbtq4xNSOk8hrAQeSeU5mwan3VTHKdgsm7hktCCTYbnMeYeHYWSHeiOELMh0t4LG9xjjmOrih8mxhmpMxwADDDDIAAM9vh2a7Dq8hvgjsmUgRGzsXLBaL02vasYHCAKdx7Afgl-mVKo1D42yEdxN7XhBXiJTTfej6aDhZiYwvw0slirIm0yBOg7D97b_VQHWCNGyRpSTESXoph9X7wTH9HvDxuwluSCvhmpsie_d2rjaZhqmwBNTdUEed3I2TJoC7xqwUQWRIwkcrcq4pj07zcjhEJ5S3QgYVi-r-1HF3xShlCB-YAV5nwX4__ww89mcfsul2BjK6NPrp_yM3KFZ-5qK8gk5uFxv43Nw6y7di6y7fwCPOkM7 priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3raxQxEA-l4uOL-Hb11BUEQdx6m002iSByFksRzi960G8hz7NQ9uy1h9a_3pnsw65W_bYkk5CdR2Zmk_0NIc-oBx8rgy_w0KhgpmSFqiIrvJPg7oKoecDvHfOP9f6CfTjgB1ukL2_VMfDkwtQO60kt1kc734_P3oLBv0kGL-tXJwxMBa9XiQI8lipgR74EjklgQYM5Gw4VWAkZU3eweeEwBAaWNeSLWE7oKiygWR6D_xh5rATs_-f2fc5__X638vI300SD05yPfpP72rtBrndxZz5rFeUm2QrNLXJl3p2s3yYvZxuEGDDLs9w0Pk_3DP16s8whHccQE3QjP2xyhw_rO2Sx9_7z7n7RVVIonBAlLYyhVRSR2sijD46FYGJdB86itKoWfiqUocrG0lleKUeh0QInqK8M9yaq6i7ZblZNuE9y6yiwEaQopGPV1FtlpypMwauZyERFMzIZOKe_togZWrS4OJyLjEx7ZmrXoZBjMYwjnbIRWetWLBrEolEsGmZ8MQzpJ_wH8TuU0ECI6NmpYbVe6s4YtfOQJlqHHwYgPa6kjKVivpYmQECqLMvIE5Svbn9FHfYAPeNYAQeYJTPyPFGgXsLynel-ZgAeIZ7WiHIyogTrdePuXod0r_wacmiOJVC4ysjToRtH4o24Jqw2iaaSEKvJMiP3WpUbXrrX4oyIkTKOuDLuaQ6_JGxxSGCpqjksq1PbX6sKPyiCLUGGUWXkddLl_8tD78526afUioOhjT7463ofkms0mWNdUDYh26frTXgEMd-pfZws-SeAwEiV priority: 102 providerName: Scholars Portal |
| Title | Autophagy and multidrug resistance in cancer |
| URI | http://lib.cqvip.com/qk/90720X/201708/7000308557.html https://onlinelibrary.wiley.com/doi/abs/10.1186%2Fs40880-017-0219-2 https://www.ncbi.nlm.nih.gov/pubmed/28646911 https://www.proquest.com/docview/1915427859 https://www.proquest.com/docview/1913829381 https://d.wanfangdata.com.cn/periodical/ez201708003 https://pubmed.ncbi.nlm.nih.gov/PMC5482965 https://doaj.org/article/cd871bc6907549388f194d68ae0839b4 |
| Volume | 36 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3daxQxEA-lRfBFFL9Wz3MFQRAX7_KxSXy7Hi1FaClq4d5CPq8F2dNrD9G_3pns3rZrQR98WY5kEnKZmcxHkl8IeU0D2FgVQ4WbRhW3U15plngVvAJzF2UtIuY7jk_qozP-cSEWO2S-vQvT4kP0CTfUjLxeo4Jb171CkvccLjkoCB6qkhXYKV3BOryHV2zxXB_lp9eJFoQYz2iUFIKuioGL3u1uQj_vb_WCGAvnq2b5HSzHwFZlSP_bC_cNy_Xnqco7P2yTLHZz0-_NhuvwPrnXeZzlrBWRB2QnNg_Ju9kGEQXs8mdpm1DmY4VhvVmWEH2jRwmiUF40pccf60fk7PDgy_yo6h5OqLyUU1pZS1mSibokUoiex2hTXUfBk3K6lmEitaXapal3gmlPodApCEQCsyLYpNljstusmviUlM5TiDOBaVJ5zibBaTfRcQJGzCYuGS3IqJ8u860FyDCyhcERQhZksp1B4zvQcXz74qvJwYeqTcsAAwwwyAADPb7tm2w7_AvxPrKlJ0Sw7FywWi9Np3vGB4gKncc8AETDTKk01TzUykbwP7XjBXmJTDXtzdNe5c1M4IM3MFmqIG8yBSo9DN_b7u4CzBHCZw0oRwNKUFY_rN4KjukWi0sDIbPAF0-ELsirvhpb4gG4Jq42mYYpcM3UtCBPWjnr_zQF3tVgtAoiBxI4mJVhTXNxnqHEQRmorgUMq5PV61HFXxSxlSCgYAX5kAX43_ww89mcfs6l2BjK6LP_afyc3KVZN-uK8hHZvVpv4gvwAq_cOGs5fOVCjsne_sHJ6adxzqjA95ircU7c_QY_4U9U |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1daxQxMJSK6Isofq2edgVFEJfuZjebRBA5T8vVfrzYQt9iNh_Xguy1dz1K_VH-Rmeye3tdhfrUtyWZhOzMZD6SyQwhr6kFHSucTfDSKCl0ViQy90VijQB153jJHJ537O2X48Pi2xE7WiO_l29hMKxyKRODoLZTg2fkm-BXMCwLweSn07MEq0bh7eqyhEbDFjvu8gJctvnH7S9A3zeUbn09GI2TtqpAYjjPaKI1zT33tPLMW2cK57QvS8cKLypZcptyqamsfGYqlktDobESYKXbXDOrPSZfApF_CxRvis4eP-KrMx3MZs7y9vI0E-XmvIBdjJFfPAFlKhOKKRyOp_XkDBRTTxWGigH_6oUrivHvoM3bF7r2Gqe5alYHvbh1n9xrDdp42HDgA7Lm6ofk_XCBCQv05DLWtY1D1KKdLSYxOPdosAKnxSd1bPBj9ogc3ggGH5P1elq7pySuDAU3FniCC1Pkqa1klUqXgo7UvuA5jcigQ5c6bfJvKN5k2WGMRyRdYlCZNqc5ltb4qYJvI0rVEEABARQSQMGM77ohywmvAf6MZOkAMRd3aJjOJqrd2spYcDorg8cM4GznQvhMFrYU2oF5K6siIhtIVNU8bO0kihoyrKcDyBIReRsgUKbA8o1un0YAjjA7Vw9y0IMEWWD63UvGUa0smqvVzonIq64bR2J8Xe2miwCTC7D8RBaRJw2fdT9NgXYl6MSI8B4H9rDS76lPjkOmcnCHqSwZLKvl1dWq3C-KqZvAX8kj8iEw8P_poUbDEf0eWnEwtNFn1__yBrkzPtjbVbvb-zvPyV0admKZ0GJA1s9nC_cCTMrz6mXYxzH5cdOC4w-d-YIq |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1baxQxFA6lRfFFFG-jqx1BEcTB3UwySQQf1q1La7UIulJ8iZlctgWZrbtdSv1b_kHPycxOOxb0Qfq2ZE5C9txPLl8IeUIdxFjpXYabRhkzA5apPLDMWQnhzouCe1zv-LBXbE_Yu32-v0Z-re7C1PgQ7YIbWkb012jgRy7URh73HBYMDAQPVYkM4pTKaHOyctefnkDdtni9swVCfkrp-O3n0XbWPC2QWSEGNDOG5kEEWgYenLfMexOKwnMWZKkK4fpCGarKMLAlz5Wl0FhKSNVdbrgzARGYwO9vcIiG_XWyMfwy-To5W9pBUPOIf0mhzMtyKAqa_VSY-csL80ZUh4NZNf0BsaoTHeMjAhdDxblY-ec5zisnpgoGhzmfacdQOb5Brjc5bjqslfImWfPVLfJiuEQMAzM9TU3l0niQ0c2X0xTqfcxhQfnSwyq1-GN-m0wuhZ93yHo1q_w9kpaWQmULaiKkZXnflarsK9-HsGkCEzlNSK9llz6qITm0qIF3OBcJ6a84qG0Dc46vbXzXsdyRha4FoEEAGgWgYcTnbZfVgH8hfoNiaQkRnjs2zOZT3Vi7tg7q0NLiygPU37mUYaCYK6TxkPGqkiVkE4Wq67uurZPRQ45P7ACzZEKeRQp0MzB9a5rbEsAjBOzqUPY6lOAebPfzSnF0454WGop0jm-scJWQx-1n7IlH7io_W0aaXEIyKAcJuVvrWfunKciugDCZENHRwA5Xul-qw4MIXg7GQFXBYVqNrp7Nyv-kiOYEJUyekFdRgf8tDz0ajuin2IqdoY3e_5_Om-Tqx62xfr-zt_uAXKPRTIuMsh5ZP54v_UNIQY_LR43Jp-TbZXuZ3xSYinc |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Autophagy+and+multidrug+resistance+in+cancer&rft.jtitle=Cancer+communications+%28London%2C+England%29&rft.au=Li%2C+Ying%E2%80%90Jie&rft.au=Lei%2C+Yu%E2%80%90He&rft.au=Yao%2C+Nan&rft.au=Wang%2C+Chen%E2%80%90Ran&rft.date=2017-06-24&rft.pub=BioMed+Central&rft.issn=2523-3548&rft.eissn=2523-3548&rft.volume=36&rft.issue=1&rft.spage=1&rft.epage=10&rft_id=info:doi/10.1186%2Fs40880-017-0219-2&rft.externalDBID=10.1186%252Fs40880-017-0219-2&rft.externalDocID=CAC2S4088001702192 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F90720X%2F90720X.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fez%2Fez.jpg |